Literature DB >> 16204605

Standardisation of the single-breath determination of carbon monoxide uptake in the lung.

N Macintyre1, R O Crapo, G Viegi, D C Johnson, C P M van der Grinten, V Brusasco, F Burgos, R Casaburi, A Coates, P Enright, P Gustafsson, J Hankinson, R Jensen, R McKay, M R Miller, D Navajas, O F Pedersen, R Pellegrino, J Wanger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16204605     DOI： 10.1183/09031936.05.00034905

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  610 in total

1.  Objectively Measured Disrupted Sleep Is Independently and Directly Associated With Low Exercise Capacity in Males: A Structural Equation Model.

Authors:  Ren-Jing Huang; Shin-Da Lee; Ching-Hsiang Lai; Shen-Wen Chang; Ai-Hui Chung; Chiung-Wei Chen; I-Ning Huang; Hua Ting
Journal:  J Clin Sleep Med       Date:  2018-12-15       Impact factor: 4.062

2.  Canadian Thoracic Society Pulmonary Function Standards Committee.

Authors:  Allan L Coates
Journal:  Can Respir J       Date:  2011 Nov-Dec       Impact factor: 2.409

Review 3.  Nitric oxide in adaptation to altitude.

Authors:  Cynthia M Beall; Daniel Laskowski; Serpil C Erzurum
Journal:  Free Radic Biol Med       Date:  2012-01-20       Impact factor: 7.376

4.  8-Foot-Up-and-Go Test is Associated with Hospitalizations and Mortality in Idiopathic Pulmonary Fibrosis: A Prospective Pilot Study.

Authors:  Baruch Vainshelboim; Mordechai Reuven Kramer; Jonathan Myers; Avraham Unterman; Shimon Izhakian; Jose Oliveira
Journal:  Lung       Date:  2019-01-02       Impact factor: 2.584

5.  Impaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers: the Emphysema and Cancer Action Project (EMCAP) Study.

Authors:  R Graham Barr; Sonia Mesia-Vela; John H M Austin; Robert C Basner; Brad M Keller; Anthony P Reeves; Daichi Shimbo; Lori Stevenson
Journal:  Am J Respir Crit Care Med       Date:  2007-08-29       Impact factor: 21.405

6.  Quantitative and semiquantitative measures of regional pulmonary microvascular perfusion by magnetic resonance imaging and their relationships to global lung perfusion and lung diffusing capacity: the multiethnic study of atherosclerosis chronic obstructive pulmonary disease study.

Authors:  Katja Hueper; Megha A Parikh; Martin R Prince; Christian Schoenfeld; Chia Liu; David A Bluemke; Stephen M Dashnaw; Thomas A Goldstein; Eric A Hoffman; Joao A Lima; Jan Skrok; Jie Zheng; R Graham Barr; Jens Vogel-Claussen
Journal:  Invest Radiol       Date:  2013-04       Impact factor: 6.016

7.  High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis.

Authors:  David A Zisman; Arun S Karlamangla; David J Ross; Michael P Keane; John A Belperio; Rajan Saggar; Joseph P Lynch; Abbas Ardehali; Jonathan Goldin
Journal:  Chest       Date:  2007-06-15       Impact factor: 9.410

8.  Muscular and extramuscular clinical features of patients with anti-PM/Scl autoantibodies.

Authors:  Rebecca De Lorenzo; Iago Pinal-Fernandez; Wilson Huang; Jemima Albayda; Eleni Tiniakou; Cheilonda Johnson; Jose C Milisenda; Maria Casal-Dominguez; Andrea M Corse; Sonye K Danoff; Lisa Christopher-Stine; Julie J Paik; Andrew L Mammen
Journal:  Neurology       Date:  2018-05-04       Impact factor: 9.910

9.  Performance of Forced Vital Capacity and Lung Diffusion Cutpoints for Associated Radiographic Interstitial Lung Disease in Systemic Sclerosis.

Authors:  Kimberly Showalter; Aileen Hoffmann; Gerald Rouleau; David Aaby; Jungwha Lee; Carrie Richardson; Jane Dematte; Rishi Agrawal; Rowland W Chang; Monique Hinchcliff
Journal:  J Rheumatol       Date:  2018-10-01       Impact factor: 4.666

10.  Clinical characteristics of pulmonary hypertension in bronchiectasis.

Authors:  Lan Wang; Sen Jiang; Jingyun Shi; Sugang Gong; Qinhua Zhao; Rong Jiang; Ping Yuan; Bigyan Pudasaini; Jing He; Zhicheng Jing; Jinming Liu
Journal:  Front Med       Date:  2016-09-07       Impact factor: 4.592
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.